Investing.com’s stocks of the week

U.S. stocks finished a mixed Friday on track for weekly gains, with notable individual movements driven by earnings, M&A speculation, and AI demand. Oracle surged over 26% for the week, propelled by strong AI pipeline momentum and a significant increase in contracted backlog despite an earnings miss, while Warner Bros. Discovery rallied nearly 60% on reports of a potential takeover bid. Conversely, Synopsys plummeted over 30% following disappointing earnings and guidance; meanwhile, UnitedHealth gained 14.5% after reaffirming 2025 EPS and positive Medicare Advantage star ratings, and SanDisk jumped over 28% due to renewed analyst optimism for NAND market growth driven by AI inference demand.

Analysis

While U.S. major indices posted weekly gains, significant performance divergence was evident at the individual stock level, driven by catalysts in artificial intelligence, M&A, and corporate earnings. Artificial intelligence momentum was a primary theme, propelling Oracle (ORCL) up 26.3% for the week despite an earnings miss; the market instead focused on its future potential, evidenced by a $317 billion surge in contracted backlog to a total of $455 billion in a single quarter. Similarly, SanDisk (SNDK) rallied over 28% on analyst commentary identifying renewed growth in the NAND market fueled by AI inference demand. Event-driven speculation was another key factor, as Warner Bros. Discovery (WBD) soared 59.4% on reports of a potential takeover bid from Paramount Skydance, with analysts noting a deal could clear the CEO's contractual price threshold of $16.80 per share. In contrast, fundamental weakness was severely punished, with Synopsys (SNPS) plummeting 30.4% after its earnings, revenue, and guidance all fell significantly short of expectations, leading to an analyst downgrade. Finally, UnitedHealth (UNH) gained 14.5% by providing stability through a reaffirmation of its 2025 adjusted EPS guidance and a positive preliminary outlook for its Medicare Advantage star ratings.

Key Decisions for Investors

• For Oracle, investors should prioritize forward-looking AI metrics like contracted backlog and RPO growth over headline earnings, as the market is currently valuing the company based on its transformation into an AI infrastructure provider.
• The sharp divergence between AI-exposed names like Oracle and SanDisk and the fundamentally weak Synopsys underscores the need for selective investment; even in a strong market, a significant guidance miss can trigger major downside.
• Positions in Warner Bros. Discovery should be considered highly speculative, given the 59.4% rally is predicated on M&A rumors, making the stock sensitive to any news flow regarding the potential Paramount Skydance bid.
• UnitedHealth's reaffirmed 2025 EPS guidance offers a basis for stability, but investors should monitor for the finalization of its 2026 Medicare Advantage star ratings, as the currently positive data remains preliminary and subject to change.